Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
0.8305
+0.0005 (0.06%)
Jun 5, 2026, 4:00 PM EDT - Market closed
ZYBT Revenue
In the year 2025, Zhengye Biotechnology Holding had annual revenue of 116.36M CNY, down -37.56%. Zhengye Biotechnology Holding had revenue of 54.03M in the half year ending December 31, 2025, a decrease of -43.00%.
Revenue (ttm)
116.36M CNY
Revenue Growth
-37.56%
P/S Ratio
2.37
Revenue / Employee
432,572 CNY
Employees
269
Market Cap
39.36M USD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 116.36M | -69.99M | -37.56% |
| Dec 31, 2024 | 186.36M | -25.30M | -11.95% |
| Dec 31, 2023 | 211.65M | -48.62M | -18.68% |
| Dec 31, 2022 | 260.27M | 46.20M | 21.58% |
| Dec 31, 2021 | 214.07M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| InterCure | 84.76M |
| Rockwell Medical | 67.68M |
| Aytu BioPharma | 56.60M |
| BGM Group | 25.10M |
| SCYNEXIS | 20.34M |
| China Pharma Holdings | 3.99M |
| TherapeuticsMD | 3.35M |
| BioXcel Therapeutics | 680.00K |
ZYBT News
- 3 days ago - Zhengye Biotechnology receives deficiency notice over minimum bid price - TheFly
- 3 days ago - Zhengye Biotechnology Holding Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency - GlobeNewsWire
- 5 weeks ago - Zhengye Biotechnology Holding Limited Announces Fiscal Year 2025 Financial Results - PRNewsWire
- 2 months ago - Zhengye Biotechnology Holding Limited Announces Implementation of Dual-Class Share Structure - GlobeNewsWire
- 4 months ago - Zhengye Biotechnology issues letter to shareholders - TheFly
- 4 months ago - Zhengye Biotechnology Holding Limited Issues 2026 Chairman's Letter to Shareholders - GlobeNewsWire
- 10 months ago - Zhengye Biotechnology Holding Ltd trading resumes - TheFly
- 10 months ago - Zhengye Biotechnology Holding Ltd trading halted, volatility trading pause - TheFly